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Abstract
Background: Hemophilia A is an X-linked recessive disorder caused by a deficiency in factor VIII. Hemophilia A
affects 1 in 5,000–10,000 males. Hematuria is frequent in hemophilia. Hematuria in hemophilia is generally
considered benign and manageable with conservative therapy; however, severe hematuria requiring surgical
therapy has rarely been reported.
Case presentation: A 60-year-old male with hemophilia A presented with persistent gross hematuria of unknown
cause. He was treated with recombinant factor VIII products, followed by several conservative therapies as follows: clot
evacuation by vesicoclysis, continuous bladder irrigation with normal saline, and intravesical instillation of aluminum
hydroxide/magnesium hydroxide (Maalox); however, these failed to resolve the hemorrhaging. The patient was offered
and consented to cystectomy with an ileal conduit. Intraoperative clotting was normal with the infusion of adequate
recombinant factor VIII products and transfusion of fresh-frozen plasma, and the procedure was performed safely. After
surgery, the patient had blood in his stool several times. No bleeding site was demonstrated in the colon by
colonoscopy and 99mTechnetium-human serum albumin-diethylenetriaminepenta-acetic acid scintigraphy
demonstrated that the extravasation of radioactive isotope was detected at the anal side of terminal ileum but not at
the oral side. These findings were suspected to be bleeding from the ileoileal anastomosis. However, the bleeding was
managed with recombinant factor VIII products.
Conclusions: Cystectomy in hemophilia may be safe, if monitored appropriately. Urinary diversion using the intestine
may be avoided because anastomotic hemorrhage may become a problem.
Background
Hemophilia A and B are X-linked recessive disorders
caused by deficiencies in factors VIII and IX, respectively.
Hemophilia A affects 1 in 5,000–10,000 males, whereas
hemophilia B affects 1 in 25,000–30,000 males [1].
Hematuria is a frequent manifestation of hemophilia.
Historically, hematuria in hemophilia has generally been
considered benign and manageable with conservative
therapy [1]. However, severe hematuria in hemophilia has
rarely been reported [2, 3]. Here, we present a case of
severe hematuria requiring surgical therapy. This is the
first case report to date of cystectomy with an ileal conduit
urinary diversion in a patient with hemophilia A.
Case presentation
A 60-year-old male with a mild factor VIII deficiency
presented to the hematology clinic at our hospital with
a 1-week history of asymptomatic gross hematuria. He
had suffered a hemorrhagic gastric ulcer at the age of 48
and was diagnosed with mild hemophilia A (his factor VIII
levels were 6 % of normal) at that time. He had suffered a
cerebral hemorrhage at the age of 59. For several years
beginning at the age of 50, the patient had experienced mild
hematuria, and he had experienced one episode of intra-
muscular and subcutaneous hemorrhage; both conditions
were managed with recombinant factor VIII products.
A physical examination revealed no abnormal signs.
Laboratory tests revealed that the patient’s activated
partial thromboplastin time (aPTT) was prolonged to
74.6 s (normal range, 28.5–40.9 s), but his prothrombin
time-international normalized ratio, platelet count, serum
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creatinine level, and prostate-specific antigen level were un-
remarkable. The patient’s urinalysis results were normal,
except for the gross hematuria, and urine cytology revealed
no cancer cells. The patient was treated with a third-
generation recombinant factor VIII product (Advate).
However, he had persistent hematuria, followed by clot
retention. Thus, he was referred to the Department of
Urology. Computed tomography demonstrated that his
bladder was filled with a blood clot (Fig. 1), but his pros-
tate and upper urinary tract were apparently normal.
He was admitted to our hospital and received the
following therapy: clot evacuation by vesicoclysis, continu-
ous bladder irrigation with normal saline, and intravesical
instillation of aluminum hydroxide/magnesium hydroxide
(Maalox) concurrent with the administration of Advate,
which failed to resolve the hemorrhage. Consequently, the
patient had repeated transfusions of packed red cells.
Although the patient also underwent transurethral coagu-
lation of the bladder mucosa under anesthesia, the bleed-
ing presented with oozing throughout the mucosa and
was not controlled. Subsequently, the patient developed
pyelonephritis in his left kidney with a severe reduction
(<50 mL) in his bladder capacity. Conservative manage-
ment for 2 months failed to resolve the patient’s symp-
toms, so he was offered a cystectomy with ileal conduit
and consented to it after a detailed discussion.
The quality of intraoperative clotting seemed to be
normal with the use of sufficient Advate to raise the levels
of factor VIII to 100 % (3000 U, IV bolus) and the transfu-
sion of 3 U of fresh-frozen plasma. His aPTT was 54 s
during surgery. The cystectomy was performed safely with-
out severe bleeding events. A 15-cm length of ileal segment
at 15 cm from the ileocecal valve was used for the ileal
conduit. The technique of side-to-side stapled anastomosis
was used for the ileoileal anastomosis, and the Bricker
anastomosis technique was used for ureteroileal anasto-
mosis. The total operating time was 220 min and the
estimated blood loss was 800 mL.
The resected specimen revealed multiple erosions and
ulcers in the bladder mucosa, and sclerosis of the blad-
der wall. Histological examinations demonstrated in-
flammatory cell infiltration and fibrous changes in the
bladder wall without malignant figures. The cause of
the hematuria was unclear.
Postoperatively, Advate (3000 U, q12 h) was administered
to maintain 100 % levels of factor VIII for 2 days with no
bleeding complications. After removal of the ureteral
catheters on postoperative day 13, the patient had urinary
leakage from the ureteroileal anastomosis, which induced a
pelvic abscess followed by septic shock and acute respira-
tory distress syndrome. Blood cultures were positive for
Candida tropicalis. Several antibiotics and surgical drainage
of the abscess were needed.
At 4 months after the cystectomy, the patient had
blood in his stool requiring a transfusion of packed red
cells. No bleeding site was demonstrated in the colon by
colonoscopy and 99mTechnetium-human serum albumin-
diethylenetriaminepenta-acetic acid scintigraphy demon-
strated that the extravasation of radioactive isotope was
detected at terminal ileum, cecum, ascending and trans-
verse colon but not at the oral side of terminal ileum
(Fig. 2). These findings were suspected to be bleeding from
the ileoileal anastomosis. The patient was given Advate
(2000–4000 U) three times per week for 6 months, and the
Fig. 1 Computed tomography demonstrated that the bladder was
filled with a blood clot (arrow)
Fig. 2 99mTechnetium-human serum albumin-
diethylenetriaminepenta-acetic acid scintigraphy demonstrated that
the extravasation of radioactive isotope was detected at terminal
ileum, cecum, ascending and transverse colon (arrow), but not at
the oral side of terminal ileum
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blood in his stool resolved. His condition recovered grad-
ually and he was discharged at 8 months after admission.
After discharge, he had mild gastrointestinal bleeding
and mild hematuria several times a year; however, this
was controlled by Advate. The patient had been doing
well, other than the bleeding tendency, until he suffered
a malignant lymphoma at the age of 66 and was trans-
ferred to another clinic for treatment.
Discussion
Hemophilia A and B are rare X-linked recessive disor-
ders caused by deficiencies in factors VIII and IX, re-
spectively. They exhibit a range of clinical severity that
correlates well with assayed factor VIII and IX levels.
Severe disease is defined as < 1 % factor activity,
whereas 1–5 % and > 5 % of normal are deemed moder-
ate and mild disease, respectively [4]. Hematuria is a
frequent manifestation of hemophilia. In two studies of
hemophiliacs, 66 % had a history of hematuria [5, 6].
The etiology of hematuria is broad, ranging from benign
causes to potentially life-threatening malignancies, in-
cluding bladder cancer, renal cell cancer, and prostate
cancer [7]. However, the etiology of hematuria in
hemophilia is often unclear, and it may be attributable
to the underlying coagulation deficiency [1]. Historic-
ally, hematuria in hemophiliacs is generally considered
benign in nature and usually responds to conservative
therapies, including hydration, bed rest, and infusions
of factor concentrate [1]. However, severe hematuria in
classic or acquired hemophilia has rarely been reported
[2, 3]. In our case, severe hematuria occurred without any
obvious cause except the hemophilia, and persisted despite
several conservative therapies. After failure of several con-
servative therapies we next chose a surgical treatment,
cystectomy, because he had not only severe hematuria but
also pyelonephritis with a severe reduction in his bladder
capacity although selective embolization of any major
bleeding vessels prior to cystectomy may also be one of
treatment options. Histological analyses, which indicated
non-specific inflammatory cell infiltration in the bladder,
also failed to demonstrate the cause of the hemorrhage.
Performing a surgical procedure in hemophiliac pa-
tients is a demanding challenge for the surgeon and
hematologist. Various open abdominal operations, in-
cluding appendectomy, cholecystectomy, splenectomy,
and gastric/intestinal procedures, in patients with
hemophilia of varying degrees of severity have been re-
ported [8]. In the urology field, successful prostatecto-
mies for prostate cancer in hemophiliac patients have
been reported [9, 10]. However, cystectomy in a
hemophiliac patient has not been reported before. In
our case, with adequate intraoperative factor replace-
ment therapy and the transfusion of fresh-frozen
plasma, the quality of intraoperative clotting seemed to
be normal and the cystectomy was performed safely.
Our patient experienced urinary leakage from the ureter-
oileal anastomosis after removal of the ureteral stent,
leading to abscess formation and sepsis. The time to stent
removal on postoperative day 13 was supposed to be
sufficient. The rate of urinary leakage from an anastomosis
has been reported to be ~2 % with the routine use of soft
plastic stents placed across the ureteroenteric anastomosis
[11]. However, it has been reported that wound healing is
impaired in hemophilia but that normal healing can be
obtained with adequate hemostatic replacement therapy for
7 days [12, 13]. It is possible that tissue healing at an anas-
tomosis is also impaired in hemophilia. Adequate factor
VIII concentrate for an extended period of time and the
delay of stent removal at an anastomotic site may be re-
quired in hemophiliac patients. Stentogram before removal
of ureteric stent after ileal conduit construction may also be
required to detect leakage of urine at the ureteroenteric
anastomosis in hemophiliac patients although routine post-
operative stentogram is not recommended in patients with
a normal postoperative course [14].
Our patient also had intestinal bleeding, probably
from the ileoileal anastomosis. Generally, anastomotic
hemorrhage is considered a rare entity. To our know-
ledge, there is no previous report on an ileoileal anas-
tomotic hemorrhage. The incidence of colorectal
anastomotic hemorrhage is reported to be as high as
5 % [15]. There is one report of a severe anastomotic
hemorrhage in a hemophiliac patient after total gas-
trectomy with a Roux-en-Y reconstruction [16]. The
intestinal bleeding in our case was likely attributable to
his bleeding tendency. Because anastomotic bleeding
may be serious in hemophilia, urinary diversion using
the intestine should be avoided if possible.
Conclusion
To our knowledge, this is the first case report of cystectomy
in a patient with hemophilia A. In our case, the procedure
was performed safely with normal intraoperative clotting,
but ureteroileal anastomotic leakage and intestinal bleeding
were problematic.
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